Even Dividend Stocks Beating Palantir: Is It Time to Buy?
Palantir remains a topic of debate as dividend-focused peers outperform in choppy markets. Here’s how the latest move...
Discover effective ways to use your points for travel. Maximize your rewards and create unforgettable travel experiences.
22,746 articlesPalantir remains a topic of debate as dividend-focused peers outperform in choppy markets. Here’s how the latest move...
MegPrime, a Megatel Homes affiliate, launches a crypto rewards program that turns rent into savings through MP tokens...
The 2026 Hedge Fund Alternative Manager Forum brought together leaders to share how AI, data, and differentiated stra...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
Bitcoin logged a fresh multi-week low as markets opened, but hype defies altcoin crash with notable gains in HYPE and...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Investors are watching a growing wave of AI IPO chatter. If OpenAI opts for a confidential filing, understanding the ...
A fresh round of U.S. quantum funding sparked optimism in the stock market today, lifting IonQ and other quantum play...
A major private markets investor recently exited its position in Paymentus Holdings, shedding a sizable stake in a mo...
Lockup terms can shape the first days of a stock's life after an IPO. This guide explains standard practices, what an...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
Investors are watching Ambarella’s path to 2027 with a focus on growth drivers, margins, and the long-term AI camera ...